Heart-rate variability (HRV) biofeedback for gut–brain symptoms
Official title: A Heart Rate Variability (HRV) Biofeedback Training to Reduce Symptomatology Associated With Functional Gastrointestinal Disorders (FGID) in College Students.
Run by Fondazione Don Carlo Gnocchi ETS · NCT06687057 · Data updated 2026-11-12
This project tests whether HRV biofeedback can reduce stress and gut symptoms in college students who have functional gastrointestinal disorders and clinically significant anxiety.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Fondazione Don Carlo Gnocchi ETS Academic / other |
| Locations | 1 site (Milan) |
| Status | Recruiting |
| Started | December 1, 2024 |
| Main results expected | November 30, 2025 |
| Study ends | January 31, 2026 |
| Registry record updated | August 24, 2025 |
| Trial ID | NCT06687057 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are college-aged adults with clinically significant anxiety (DASS-21 > 4) and notable FGID symptoms (IBS-SSS > 75) who have no organic gastrointestinal disease and no major cardiac or neurological conditions.
✕Probably not a fit
People with diagnosed organic GI diseases, significant cardiovascular or neurological disorders, or without clinically significant anxiety or FGID symptom scores are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
College students with functional gastrointestinal disorder symptoms and elevated anxiety will be identified through online screening and enrolled at the Milan site. Eligible participants (IBS-SSS > 75 and DASS-21 anxiety > 4, without organic GI, cardiovascular, or major neurological disease) will be assigned to receive HRV biofeedback training or a placebo training. The interventions aim to change autonomic balance, and outcomes will include changes in HRV metrics, stress/anxiety scores, and validated GI symptom scales. Data will be collected before and after the training to compare symptom and physiological changes between groups.
Why it matters
Potential benefit: If successful, the approach could provide a non-drug way to lower stress and reduce functional GI symptoms by improving autonomic regulation.
How similar studies have gone: Prior small studies and pilot work indicate HRV biofeedback can improve parasympathetic tone and reduce stress, with some promising but not yet definitive results for symptom relief in FGIDs.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * presence of clinically significant anxiety symptoms (DASS-21 \> 4) * presence of symptoms related to Functional Gastrointestinal Disorders (in English, known as Functional Gastrointestinal Disorders (FGIDs)) (IBS-SSS \> 75); * obtaining informed consent to participate in the study; * Absence of organic gastrointestinal diseases: thus, they will be excluded if with a current or previous diagnosis of intestinal disease (e.g., ulcerative colitis); * absence of clinical conditions including neurological disorders (previous head trauma, degenerative neurological disorders, stroke, etc.) and cardiovascular disorders (hypertension, cardiac arrhythmias, etc.). Exclusion Criteria: * absence of clinically significant anxiety symptoms (DASS-21\< 4); * absence of symptoms related to Functional Gastrointestinal Disorders (in English, known as Functional Gastrointestinal Disorders (FGIDs)) (IBS-SSS \< 75); * lack of obtaining Informed Consent to participate in the study; * presence of organic gastrointestinal diseases: therefore, they will be excluded if with a current or previous diagnosis of intestinal disease (e.g., ulcerative colitis). * presence of clinical conditions including neurological disorders (previous head trauma, degenerative neurological disorders, stroke, etc.) and cardiovascular disorders (hypertension, cardiac arrhythmias, etc.).
Where it's running
-
Eleonora Volpato
Milan, Italy Recruiting
Study contacts
- Study coordinator: Eleonora Volpato, PsyD, PhD
- Email: eleonora.volpato@unicatt.it
- Phone: 3293782692
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Multi-strain Bacillus probiotic for cesarean-delivered newborns
This study tests whether daily multi-strain Bacillus spore probiotics help cesarean-born newborns grow better and have fewer tummy troubles by supporting a healthier gut microbiota.
-
Guided imagery therapy app for kids with functional abdominal pain
This study tests a guided imagery therapy app to see if it helps school-age children with functional abdominal pain disorders.
-
How different FODMAP diets affect people with IBS and functional dyspepsia
This test will try low FODMAP, gentle FODMAP, and standard dietary advice in adults with IBS or functional dyspepsia to see how they change symptoms, gut bacteria, gut barrier function, and quality of life.
-
Personalized neurostimulation for children with gastrointestinal disorders
This study is testing a new treatment that combines personalized nerve stimulation and hypnotherapy to see if it can help children with stomach problems feel better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.